Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 0615-8510

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 0615-8510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Venlafaxine Er Caps 8509 8510 1)

Chemical structure of venlafaxine hydrochloride, depicted with functional groups including a methoxy-substituted phenyl ring, a hydroxyl group, and an amine group with associated hydrochloride ion.*

FDA Label Image

Figure-1 (Venlafaxine Er Caps 8509 8510 2)

A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its O-desmethyl metabolite (ODV) across different special populations, including hepatic impairment, renal impairment, CYP2D6 metabolizer status, age, and gender. The x-axis represents change relative to the reference value, ranging from 0 to 3.5, with data points displayed for each condition.*

FDA Label Image

Figure-2 (Venlafaxine Er Caps 8509 8510 3)

A chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, ODV) of venlafaxine with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. It presents changes relative to a reference value for each drug interaction.*

FDA Label Image

Figure-3 (Venlafaxine Er Caps 8509 8510 4)

A scatter plot chart showing fold change and 90% confidence intervals for various interacting drugs and their analytes related to pharmacokinetic parameters Cmax and AUC. The x-axis represents change relative to a reference value, ranging from below 0.5 to above 3. Multiple drugs such as Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium are plotted with corresponding points and error bars.*

FDA Label Image

Principal Display Panel (Venlafaxine Er Caps 8509 8510 5)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, with a quantity of 30 capsules. The product is labeled by NCS HealthCare of KY, LLC dba Vangard Labs and manufactured by Granules India for Granules Pharmaceutical. The label includes multiple barcodes, lot number 8509, and storage instructions, along with a section for institutional use, receipt records, and dosage directions referencing the package insert.*

FDA Label Image

Principal Display Panel (Venlafaxine Er Caps 8509 8510 6)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg, clearly showing the product name, dosage form, and strength. The label displays quantity 30, lot number, expiration, and manufacturer details (Granules India for Granules Pharmaceutical). Packaged by Vangard Labs in Glasgow, KY. The label includes storage instructions, barcode, and multiple small barcode stickers with product information for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.